Anika Therapeutics, Inc. (ANIK)
21.60
+0.20
(+0.93%)
USD |
NASDAQ |
Aug 26, 14:32
Anika Therapeutics Total Return Level : 21.40 for Aug. 25, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 25, 2026 | 21.40 |
| August 24, 2026 | 21.34 |
| August 21, 2026 | 21.78 |
| August 20, 2026 | 21.34 |
| August 19, 2026 | 21.26 |
| August 18, 2026 | 21.57 |
| August 17, 2026 | 21.47 |
| August 14, 2026 | 21.50 |
| August 13, 2026 | 21.17 |
| August 12, 2026 | 22.03 |
| August 11, 2026 | 21.23 |
| August 10, 2026 | 20.68 |
| August 07, 2026 | 21.42 |
| August 06, 2026 | 20.16 |
| August 05, 2026 | 19.19 |
| August 04, 2026 | 19.61 |
| August 03, 2026 | 20.74 |
| July 31, 2026 | 19.28 |
| July 30, 2026 | 18.07 |
| July 29, 2026 | 16.17 |
| July 28, 2026 | 15.15 |
| July 27, 2026 | 15.02 |
| July 24, 2026 | 14.95 |
| July 23, 2026 | 14.67 |
| July 22, 2026 | 15.01 |
| Date | Value |
|---|---|
| July 21, 2026 | 15.16 |
| July 20, 2026 | 15.06 |
| July 17, 2026 | 15.25 |
| July 16, 2026 | 15.82 |
| July 15, 2026 | 15.93 |
| July 14, 2026 | 15.52 |
| July 13, 2026 | 15.77 |
| July 10, 2026 | 15.60 |
| July 09, 2026 | 16.09 |
| July 08, 2026 | 16.34 |
| July 07, 2026 | 15.87 |
| July 06, 2026 | 16.03 |
| July 02, 2026 | 15.36 |
| July 01, 2026 | 15.18 |
| June 30, 2026 | 14.63 |
| June 29, 2026 | 15.01 |
| June 26, 2026 | 15.10 |
| June 25, 2026 | 14.62 |
| June 24, 2026 | 14.73 |
| June 23, 2026 | 14.59 |
| June 22, 2026 | 14.20 |
| June 18, 2026 | 14.42 |
| June 17, 2026 | 14.23 |
| June 16, 2026 | 14.30 |
| June 15, 2026 | 14.61 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Perspective Therapeutics, Inc. | 3.29 |
| MiMedx Group, Inc. | 4.34 |
| ABVC BioPharma, Inc. | 0.7999 |
| Enovis Corp. | 25.58 |
| Edwards Lifesciences Corp. | 90.87 |